Head and neck squamous cell carcinoma is the most common pathological type of the head
and neck tumor, and its incidence is increasing annually. Most cases are discovered only in …

随着肿瘤免疫, 基因技术及分子生物学技术的迅速发展, 免疫治疗已经成为头颈部肿瘤治疗应用
前景较广的一种方法. 免疫治疗能激发和增强机体的免疫机能, 从而杀伤肿瘤细胞或抑制其生长 …

头颈部鳞状细胞癌 (鳞癌) 作为一种免疫抑制性肿瘤, 免疫逃逸及 T 细胞信号的破坏是其发生
发展的重要机制, 免疫治疗以此为靶点通过其独特的作用机制在头颈部鳞癌的治疗中成为了又一 …

Therapeutic vaccination is one of the most effective immunotherapeutic approaches, second
only to immune checkpoint inhibitors (ICIs), which have already been approved for clinical …

Head and neck (HN) cancer represents one of the most challenging diseases because the
mortality remains high despite advances in early diagnosis and treatment. Although vaccine …

Simple Summary Therapeutic vaccines are given to patients with cancer, as opposed to
prophylactic vaccines given to a healthy population. The challenge for therapeutic …

The treatment of unresectable or metastatic Head and Neck Squamous Cell Carcinoma
(HNSCC) has traditionally relied on chemotherapy or radiotherapy, yielding suboptimal …

头颈部鳞状细胞癌是人类第6 大恶性肿瘤, 目前主要的治疗手段包括手术,
放化疗等对晚期进展病患的效果不甚理想. 肿瘤免疫治疗是指应用各种免疫学方法 …

鼻咽癌抗独特型抗体疫苗的研究进展-[维普官方网站]-www.cqvip.com-维普网  我的维普 购物车
充值 客服 首页 | 期刊大全 | 文献分类 | 优先出版 | 论文检测 | 论文选题 | 在线分享 | 学者空间 | 学术 …

Vaccine‐based approaches for the treatment of advanced squamous cell carcinoma of the
head and neck have achieved very limited success. Improvement in vaccine efficacy for both …